Literature DB >> 17804127

Oral mucosal diseases: mucous membrane pemphigoid.

Crispian Scully1, Lorenzo Lo Muzio.   

Abstract

Subepithelial vesiculobullous conditions are chronic autoimmune disorders that arise from reactions directed against components of the hemidesmosomes or basement membrane zones (BMZ) of stratified squamous epithelium to which the term immune-mediated subepithelial blistering diseases (IMSEBD) has been given. Mucous membrane pemphigoid (MMP) is the most common, but variants do exist. Non-immune disorders that involve these epithelial components typically have a genetic basis--the main example being epidermolysis bullosa. All subepithelial vesiculobullous disorders present as blisters and erosions, and diagnosis must be confirmed by biopsy examination with immunostaining, sometimes supplemented by other investigations. No single treatment reliably controls all subepithelial vesiculobullous disorders; the immunological differences within IMSEBD may account for differences in responses to treatment. Currently, as well as improving oral hygiene, immunomodulatory treatment is used to control the oral lesions of MMP, but it is not known if its specific subsets reliably respond to different agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804127     DOI: 10.1016/j.bjoms.2007.07.200

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  14 in total

1.  Low-level laser therapy for oral mucous membrane pemphigoid.

Authors:  Adriana Cafaro; Roberto Broccoletti; Paolo Giacomo Arduino
Journal:  Lasers Med Sci       Date:  2012-06-16       Impact factor: 3.161

Review 2.  Oral lichenoid lesions: distinguishing the benign from the deadly.

Authors:  Susan Müller
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

3.  Periodontal clinical and microbiological data in desquamative gingivitis patients.

Authors:  Lucio Lo Russo; Crescenzio Gallo; Gioacchino Pellegrino; Lorenzo Lo Muzio; Giuseppe Pizzo; Giuseppina Campisi; Olga Di Fede
Journal:  Clin Oral Investig       Date:  2013-07-31       Impact factor: 3.573

4.  A gene network bioinformatics analysis for pemphigoid autoimmune blistering diseases.

Authors:  Antonio Barone; Paolo Toti; Maria Rita Giuca; Giacomo Derchi; Ugo Covani
Journal:  Clin Oral Investig       Date:  2014-11-08       Impact factor: 3.573

5.  Anti-BP180-type mucous membrane pemphigoid: report of two cases.

Authors:  Mayumi Wada; Jun Sato; Masanobu Shindoh; Hideyuki Ujiie; Ken Natsuga; Wataru Nishie; Hiroshi Shimizu; Yoshimasa Kitagawa
Journal:  Odontology       Date:  2014-10-30       Impact factor: 2.634

6.  Mucous membrane pemphigoid in HIV patient: a case report.

Authors:  Adriana Demathé; Lívia T Arede; Glauco I Miyahara
Journal:  Cases J       Date:  2008-11-22

7.  HIV patient with mucous membrane pemphigoid: a case report.

Authors:  Anand Pratap Singh; T R Chaitra; T L Ravishankar; Surendra Pratap Singh; Ashok Kumar Mohapatra
Journal:  Ethiop J Health Sci       Date:  2014-04

8.  Oral mucous membrane pemphigoid - Two case reports with varied clinical presentation.

Authors:  Sreedevi Dharman; Arvind Muthukrishnan
Journal:  J Indian Soc Periodontol       Date:  2016 Nov-Dec

9.  Mucous membrane pemphigoid in a patient with hypertension treated with atenolol: a case report.

Authors:  Patnarin Kanjanabuch; Samornroj Arporniem; Suparat Thamrat; Pannipa Thumasombut
Journal:  J Med Case Rep       Date:  2012-10-31

10.  Desquamative gingivitis - A clinical sign in mucous membrane pemphigoid: Report of a case and review of literature.

Authors:  Shamimul Hasan
Journal:  J Pharm Bioallied Sci       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.